Larvol Delta - Caribou-Biosciences-Selects-ROR1-as-the-Target-for-CB020-an-iPSCderived-Allogeneic-CARNK-Cell-Therapy

CB-020 - Caribou Biosci

https://www.globenewswire.com/news-release/2022/12/12/2571795/0/en/Caribou-Biosciences-Selects-ROR1-as-the-Target-for-CB-020-an-iPSC-derived-Allogeneic-CAR-NK-Cell-Therapy.html

Dec 12, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next